BioWorld MedTech

Nov. 3, 2011

Mela Sciences secures PMA for MelaFind after lengthy delays

Mela Sciences (Irvington, New York) reported that it has received a PMA for its MelaFind skin cancer detection device, after intense discussion with the FDA regarding the device throughout the past few years. Read More

VitroStealth shows potential as a coating for biosensors

International report: CoreValve system used for first time in Japanese clinical trial

Washington roundup: CMS announces 27% pay cut for Part B doc fees in FY '12

Financings roundup: Echo says warrant deal offers financial flexibility

Patent watch: Biomoda files application for CyPath refinement tool

Late-Breaking FDA valve stent approvals: Edwards gets FDA approval for Sapien transcather valve

FDA approves TriVascular's 20-mm Ovation stent system

NASS Notebook: Orthofix launches Collage bone graft substitute at NASS

Court report: MRI Associates awarded $52M in damages in case

HIT roundup: Trend renews membership with MDISS consortium

Agreements/contracts: Welch Allyn to provide EHR services to organizations

Deals roundup: Salmat's management buyout of VeCommerce is complete

Product Briefs

People in the News

MDD's Ortho Extra

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 10, 2025

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...

Illustration of Magnet Biomedicine's Trueglue platform

Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology

BioWorld

About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...